SCHEMBL30926720

SCHEMBL30926720

COc1ccc(NC(=O)c2cccc(S(=O)(=O)Nc3ccc(Cl)cc3)c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.67
KMT2A Q03164 6/20 0.67
PGR P06401 1/20 0.66
SMN1; SMN2 Q16637 2/20 0.65
NR2F2 P24468 1/20 0.65
MAPK1 P28482 1/20 0.65
HTT P42858 1/20 0.65
RAB9A P51151 1/20 0.65
MAPT P10636 3/20 0.64
NPSR1 Q6W5P4 1/20 0.64
ADORA3 P0DMS8 1/20 0.63
SLC6A3 Q01959 1/20 0.63
ALDH1A1 P00352 1/20 0.62
LMNA P02545 1/20 0.62
F2 P00734 1/20 0.61
PPIA P62937 1/20 0.61
GAA P10253 2/20 0.61
CTDSP1 Q9GZU7 2/20 0.60
POLB P06746 1/20 0.60
CACNA1B Q00975 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27181006 1.00 MEN1 (0.67) MEN1KMT2APGRSMN1; SMN2NR2F2
SCHEMBL13532171 0.91 MEN1 (0.77) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL15705229 0.90 KMT2A (0.69) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL13532178 0.90 KMT2A (0.69) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL30926541 0.89 MEN1 (0.66) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL27180042 0.89 MEN1 (0.66) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL30926445 0.89 MEN1 (0.82) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL27180991 0.89 MEN1 (0.82) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL13532193 0.89 MEN1 (0.74) MEN1KMT2ASMN1; SMN2NR2F2MAPK1
SCHEMBL27180406 0.89 MEN1 (0.82) MEN1KMT2ASMN1; SMN2NR2F2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885PGR 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.